March 21st 2025
A recent study found that polycystic ovary syndrome affects uterine cell composition and gene expression, shedding light on fertility challenges and potential treatment targets.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Risks of cervical excisional treatment and PPROM
June 30th 2023In a recent study, pregnancies with preterm prelabor rupture of membranes were associated with greater risks of intraamniotic infection, microbial invasion of the amniotic cavity without inflammation, and early-onset neonatal sepsis development in women with a history of cervical excisional treatment.
Read More
How do infant formulas compare to composition or performance of human milk?
June 19th 2023Infant formula companies add new ingredients to match or best mimic human milk and breastfeeding advantage for the child, but comparing new-ingredient formulas with existing formulas and human milk to determine efficaciousness can present clinical and ethical challenges.
Read More
Model estimates the optimal number of oocytes for ART treatment
March 15th 2023A model to estimate the optimal number of oocytes to try to fertilize during assisted reproductive technology (ART) treatment predicted that 43.4% of oocyte retrievals were day 3 transfers; hence, exposing all oocytes to sperm is recommended.
Read More
A discussion about treatment options for women's sexual dysfunction
March 9th 2023At the International Society for the Study of Women’s Sexual Health (ISSWSH) conference, held this year March 2 to 5 in St. Louis, Missouri, Contemporary OB/GYN®’s digital editor, Michael Krychman, MD, spoke with Ashley Tapscott, a board-certified urologist trained in male and female sexual dysfunction, who works in Charlotte, North Carolina.
Read More
Digital therapeutic device for urinary incontinence
March 8th 2023In study findings published in Obstetrics & Gynecology, leva Pelvic Health System (Renovia) achieved significantly greater urinary incontinence symptom improvement than a standard home pelvic floor muscle training program at 6 and 12 months.
Read More